An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas

Chen M.-H.Chou W.-C.Hsiao C.-F.Jiang S.S.Tsai H.-J.Liu Y.-C.CHIUN HSUShan Y.-S.Hung Y.-P.Hsich C.-H.Chiu C.-H.Liu T.-C.Cho S.-F.Liu T.-W.Chao Y.2022-08-192022-08-1920201083-7159https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077047878&doi=10.1634%2ftheoncologist.2019-0490&partnerID=40&md5=94f38a68b2e9542b94ee0a53402fcdb3https://scholars.lib.ntu.edu.tw/handle/123456789/617109[SDGs]SDG3An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomasjournal article10.1634/theoncologist.2019-0490318528102-s2.0-85077047878